Dose-dependent response to cyclodextrin infusion in a rat model of verapamil toxicity

Western Journal of Emergency Medicine

Volumn 13, Issue 1, 2012, Pages 63-67

  Mottram, Allan R ^a   Bryant, Sean M ^b   Aks, Steven E ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Division of Medical Toxicology   (United States)

Author keywords

Cardiotoxicity; Cyclodextrin; Rat; Verapamil

Indexed keywords

BETA CYCLODEXTRIN SULFOBUTYL ETHER; CYCLODEXTRIN; DIAZEPAM; KETAMINE; SODIUM CHLORIDE; VERAPAMIL; WATER;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ARTICLE; ASYSTOLE; BLOOD VOLUME; BODY TEMPERATURE; BREATHING RATE; COMPLEX FORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; DRUG SOLUBILITY; DRUG STABILITY; HEART RATE; HYDROPHOBICITY; HYPOTHESIS; MALE; MICELLE; NONHUMAN; OSMOLALITY; RAT;

EID: 84857823589     PISSN: 1936900X     EISSN: 19369018     Source Type: Journal    
DOI: 10.5811/westjem.2011.3.6696     Document Type: Article

References (15)

1. Challa R, Ahuja A, Ali J, et al. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech. 2005;6:E329-E357.
2. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002;41: 266-270.
3. Sparr HJ, Vermeyen KM, Beaufort AM, et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology. 2007;106:935-943. (Pubitemid 46684059)
4. Szejtli J. Comprehensive Supramolecular Chemistry. New York, NY: Elsevier; 1996.
5. Loftsson T, Magnusdottir A, Masson M, et al. Self-association and cyclodextrin solubilization of drugs. J Pharm Sci. 2002;91:2307-2316. (Pubitemid 35231194)
6. Weinberg GL, VadeBoncouer T, Ramaraju GA, et al. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998;88:1071-1075. (Pubitemid 28193335)
7. Tebbutt S, Harvey M, Nicholson T, et al. Intralipid prolongs survival in a rat model of verapamil toxicity. Acad Emerg Med. 2006;13:134-139. (Pubitemid 43155818)
8. Harvey M, Cave G. Intralipid outperforms sodium bicarbonate in a rabbit model of clomipramine toxicity. Ann Emerg Med. 2007;49:178-185.
9. Desire B, Saint-Andre S. Interaction of soman with beta-cyclodextrin. Fundam Appl Toxicol. 1986;7:646-657.
10. Desire B, Saint-Andre S. Inactivation of sarin and soman by cyclodextrins in vitro. Experientia. 1987;43:395-397. (Pubitemid 17060935)
11. Verster RS, Botha CJ. Evaluation of hydroxypropyl-beta-cyclodextrin in the treatment of aldicarb poisoning in rats. J S Afr Vet Assoc. 2004;75: 182-185.
12. May C, Stewart PL. Development of a toxin-binding agent as a treatment for tunicaminyluracil toxicity: protection against tunicamycin poisoning of sheep. Aust Vet J. 1998;76:752-756.
13. Xie GH, Skanchy DJ, Stobaugh JF. Chiral separations of enantiomeric pharmaceuticals by capillary electrophoresis using sulphobutyl ether beta-cyclodextrin as isomer selector. Biomed Chromatogr. 1997;11: 193-199. (Pubitemid 27351256)
14. Chankvetadze B, Burjanadze N, Pintore G, et al. Chiral recognition of verapamil by cyclodextrins studied with capillary electrophoresis, NMR spectroscopy, and electrospray ionization mass spectrometry. Chirality. 1999;11:635-644. (Pubitemid 29446268)
15. Mottram AR, Aks SE, Bryant SM. Effect of cyclodextrin infusion in a rat model of verapamil toxicity. Am J Ther. 2011;18:371-374.